Product image of Zoledroninezuur Accord (Zoledronic Acid) supplied by GNH India

Zoledroninezuur Accord

Active Ingredient:
Zoledronic Acid
Origin:
EU

Zoledroninezuur Accord (Zoledronic Acid)

Zoledroninezuur Accord contains zoledronic acid, a bisphosphonate used for bone health. This intravenous solution supports calcium balance and reduces bone turnover. Ideal for osteoporosis and bone metastases management. Prescription required.

Manufacturer / TM Owner

Accord Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zoledroninezuur Accord is primarily used to treat osteoporosis in postmenopausal women and men at high fracture risk. It also helps manage bone metastases from solid tumors, reducing complications like fractures. Patients with Paget’s disease of bone may benefit from its bone-strengthening effects. This medication works by slowing bone breakdown and increasing density.

Side Effects

  • This medication helps maintain bone strength by reducing mineral loss over time. Users may notice improved mobility and reduced bone pain as bone turnover decreases. Some experience temporary flu-like symptoms after administration, which typically resolve within a few days. Regular monitoring may be recommended to assess bone health progress.

Precautions & Warnings

  • Store zoledronic acid at room temperature, away from moisture and heat. Keep out of reach of children and pets. Do not use if the solution is discolored or contains particles. Inform your healthcare provider about any kidney issues before receiving this treatment. Stay well-hydrated before and after administration to support kidney function.

Avoid Interactions

  • Zoledronic acid may interact with other medications affecting calcium levels, such as diuretics or corticosteroids. Combining it with nephrotoxic drugs could increase kidney stress. Alcohol and tobacco may reduce its effectiveness in bone protection. Always disclose all medications and supplements to your healthcare provider before starting treatment.

Frequently Asked Questions

It is used to treat osteoporosis and bone metastases by strengthening bones and reducing fractures.

It is given as an intravenous infusion by a healthcare professional, typically over 15 minutes or more.

Common side effects include flu-like symptoms and bone pain, which usually resolve within a few days.

It is not recommended for use during pregnancy due to potential risks to fetal bone development.

Dosing frequency depends on the condition being treated; your doctor will determine the schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Zoledronic Acid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT